NCT02142959 2025-06-03
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Biogen
Phase 2 Completed
Biogen
Mayo Clinic
Wake Forest University Health Sciences
Abramson Cancer Center at Penn Medicine
Trans Tasman Radiation Oncology Group
Case Comprehensive Cancer Center